Imagine a smart sticker placed on the skin that can 'smell' changes in how a tumor is reacting to medicine. It picks up tiny chemical signals in sweat that act like fingerprints for cancer metabolism. This allows doctors to see if a drug is working immediately without needing invasive biopsies or waiting for a scan.
Breast cancer treatment often follows a one-size-fits-all monitoring approach, making it difficult to know if a specific drug is working for a specific patient in real-time without invasive procedures.
A wireless Lab-on-a-Patch using straintronic microwave and nanomaterials to detect volatile organic compounds in sweat.
If you are a wearable manufacturer dealing with the lack of non-invasive cancer monitoring tools — this project developed a wireless Lab-on-a-Patch that monitors therapeutic response via sweat VOCs. This allows for the creation of a new category of precision oncology wearables.
If you are a drug developer dealing with unpredictable patient responses to anticancer drugs — this project developed a system adaptable to 3D organoid models. This enables faster, more accurate drug screening by modeling tumor response to treatment.
If you are a digital health provider dealing with the 'one-size-fits-all' monitoring gap — this project developed a wireless sensor system for real-time data analysis. This enables a shift toward personalized, synchronized monitoring of tumor biology.
Based on available project data, specific pricing or production costs are not provided as the project is in the development phase.
The project involves 4 industry partners, including 2 SMEs, suggesting a focus on moving toward industrial application, though specific scaling metrics are not listed.
Based on available project data, the specific licensing terms are not disclosed, but the project utilizes cutting-edge straintronic and nanomaterials technologies.
The system is designed as a non-invasive wireless patch that provides real-time monitoring, intended to help clinicians adjust therapeutic strategies timely.
The project is active from 2024-04-01 to 2028-03-31.
The consortium is well-balanced for a translational project, consisting of 12 partners across 6 countries. With a 33% industry ratio (4 companies, including 2 SMEs) alongside 5 universities and 2 research institutes, the project has a strong bridge between fundamental materials science and commercial application.
Contact Centrale Lille Institut in France
Contact us to explore licensing opportunities for straintronic sensor technology.
